Cell Reports

Cell Reports (Cell Rep.) is an open access journal published by Cell Press. Founded in January 2012, it was the publisher's first gold open access title, publishes primary research across the life sciences that is methodologically sound and well supported, appears as one volume of twelve issues a year with continuous online publication, and had a 2025 impact factor of 7.7.《细胞报告》（Cell Reports''''，缩写 Cell Rep.''）是细胞出版社出版的开放获取刊物，2012 年 1 月创刊，是该社第一本金色开放获取期刊。该刊以生命科学各分支中方法可靠、结论扎实的原始研究为主，现为每年一卷十二期并在线连续出版，二〇二五年影响因子为 7.7。

Scope

The journal's editorial stance is that sound conclusions deserve publication: provided the methods are rigorous and the evidence matches the claims, a paper should be published even if it is not the most striking advance in its field. Coverage spans the life sciences and concentrates on:本刊的取稿立场是「结论可靠即可发表」：一篇论文只要方法严谨、证据与其结论相称，即使不属于某一领域最引人注目的突破，也应当被发表。收文覆盖生命科学的完整谱系，重点包括：

• Cell and molecular biology: the cell cycle and cytoskeleton, membrane and organelle biology, proteostasis and degradation, and regulation of gene expression.细胞与分子生物学： 细胞周期与细胞骨架、膜与细胞器生物学、蛋白质稳态与降解、基因表达调控。

• Neuroscience: neural circuits and behaviour, synapses and neural development, mechanisms of neurodegeneration, and sensory and motor systems.神经科学： 神经环路与行为、突触与神经发育、神经退行性机制、感觉与运动系统。

• Immunology and microbiology: immune cell differentiation and response, infection and host defence, the microbiome and symbiosis, and vaccine and immunotherapy mechanisms.免疫与微生物： 免疫细胞分化与应答、感染与宿主防御、微生物组与共生、疫苗与免疫治疗机制。

• Cancer biology: tumour initiation and progression, the tumour microenvironment, mechanisms of therapeutic resistance, and tumour metabolism and immune escape.癌症生物学： 肿瘤发生与演进、肿瘤微环境、治疗抵抗机制、肿瘤代谢与免疫逃逸。

• Stem cells and development: pluripotency and reprogramming, lineage commitment and differentiation, tissue regeneration and repair, and the cellular basis of development.干细胞与发育： 多能性与重编程、谱系决定与分化、组织再生与修复、发育过程的细胞基础。

• Omics and resource data: high-throughput screening and functional genomics, single-cell and spatial omics, dataset and resource papers, and computational methods and tools.组学与资源型数据： 高通量筛选与功能基因组学、单细胞与空间组学、数据集与资源型论文、计算方法与工具。

The journal has been gold open access since founding under a Creative Commons attribution licence, with an article processing charge of 5,790 US dollars. The publisher reports five days to first decision, thirty-seven days to a decision after review and 177 days to acceptance, the first-decision figure including editorial screening本刊自创刊即为金色开放获取，采用知识共享署名许可，文章处理费为五千七百九十美元；出版方公布投稿至首次决定五天、复审后决定三十七天、投稿至接收一百七十七天，其中首次决定包含编辑部初筛，录用比例未公布。 no acceptance rate is published.^[1]

History

• Founding (2012): the journal was launched in January 2012 as the first open access title from Cell Press. Boyana Konforti was the founding editor, and the rationale was to provide a dedicated platform for authors wanting to publish in a high-level gold open access journal.创刊（2012年）： 2012 年 1 月创刊，是细胞出版社创办的第一本开放获取刊物；首任主编为（Boyana Konforti）；创刊动因是为希望投稿高水平金色开放获取刊物的作者提供专属平台。^[2]

• Growth and scale: the journal published 249 papers in its first year and now regularly publishes well over a hundred a month. From 2020 it became the flagship of the Cell Press Cell Reports series, which has since expanded into medicine, methods and physical science.体系化与体量： 本刊创刊当年发表二百四十九篇，现单月常发百余篇；2020 年起成为细胞出版社「（Cell Reports）系列」的旗舰，系列陆续扩展出医学、方法与物理科学等分刊。

• Publishing format: the journal uses one volume of twelve issues a year while also publishing continuously online, so papers appear as soon as they are finalised rather than waiting for a full issue. All content has been gold open access since the first issue.出版形态： 本刊采用每年一卷十二期的卷期编排，同时在线连续出版，文章定稿后即上线而不等待整期编成；全部内容自创刊起即为金色开放获取。

• Metrics and indexing: the impact factor is 7.7 and the CiteScore 12.3. The journal is indexed in DOAJ, Scopus and MEDLINE.指标与收录： 影响因子 7.7、引用分数 12.3；本刊被 DOAJ、Scopus 与 MEDLINE 收录。^[1]

Editors

The journal also follows the Cell Press in-house professional editor model, with the editor-in-chief a professional editor appointed within the publisher. The present editor is based in the Cambridge, Massachusetts office本刊同样实行细胞出版社内部专业编辑制，主编由出版社内部任命的专业编辑担任；现任主编驻社剑桥（马萨诸塞州）办公室，其前任在离职后分别转入科研资助机构与高校研究所。 her predecessors moved on to a research funding organisation and to a university institute respectively.^[3]

• Present editor: Shawnna Buttery is an in-house professional editor at Cell Press based in Cambridge, Massachusetts. The publisher does not state the year of appointment现任主编： （Shawnna Buttery）为细胞出版社内部专业编辑，驻剑桥（马萨诸塞州）办公室；出版方未公布其就任年份，官方页面于 2025 年 7 月更新。 the official page was updated in July 2025.

• Past editors: the founding editor Boyana Konforti served from the launch in 2012 and later moved to the Howard Hughes Medical Institute历任主编： 首任主编（Boyana Konforti）自 2012 年创刊起任职，后赴霍华德·休斯医学研究所；第二任（Sabbi Lall）后赴麻省理工学院（McGovern）研究所；第三任（Stephen Matheson）2018 年至 2022 年在任。 the second, Sabbi Lall, later moved to the McGovern Institute at the Massachusetts Institute of Technology and the third, Stephen Matheson, served from 2018 to 2022.^[4]

• Role in the field: the journal established soundness as the criterion for publication, providing a high-level outlet within the Cell Press system for methodologically solid papers rejected by the flagship titles. Its sister journals in the series apply the same criterion.学科角色： 本刊确立了「可靠即发表」的评审标准，为细胞出版社体系中被顶刊拒稿但方法扎实的稿件提供了高水平出口，其系列分刊沿用同一评审口径。